Nordea Investment Management AB Has $8.90 Million Holdings in CME Group Inc. $CME

Nordea Investment Management AB grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.1% in the 2nd quarter, HoldingsChannel reports. The fund owned 32,575 shares of the financial services provider’s stock after purchasing an additional 655 shares during the quarter. Nordea Investment Management AB’s holdings in CME Group were worth $8,899,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Webster Bank N. A. increased its holdings in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the period. Highline Wealth Partners LLC increased its holdings in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Wayfinding Financial LLC bought a new position in CME Group in the first quarter valued at approximately $25,000. Cornerstone Planning Group LLC increased its stake in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Finally, Trifecta Capital Advisors LLC increased its stake in CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

NASDAQ CME opened at $267.62 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The stock has a market cap of $96.44 billion, a PE ratio of 25.91, a PEG ratio of 6.16 and a beta of 0.41. The firm’s fifty day moving average price is $266.94 and its two-hundred day moving average price is $271.50.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the firm posted $2.56 earnings per share. CME Group’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is currently 48.40%.

Insider Buying and Selling at CME Group

In related news, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider owned 17,440 shares of the company’s stock, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,043 shares of company stock worth $3,527,956. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on CME shares. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Morgan Stanley lifted their price objective on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, October 1st. Barclays decreased their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday, October 14th. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $283.71.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.